Virtual Medicinal Product (VMP)
-
Olipudase alfa 20mg powder for solution for infusion vials
Name Details
Current Name
Olipudase alfa 20mg powder for solution for infusion vials
|
Start Date
20-12-2022
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A16AB25
SNOMED Codes
Code
|
Start Date
|
End Date
|
41346111000001109 |
20-12-2022 |
|
VMP Ingredients
VMP ingredients table
Olipudase alfa |
Based on Ingredient Substance |
|
20 mg |
|
Name
Olipudase alfa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
Parent Products
-
VTM
Olipudase alfa
-
VMP
(Current) Olipudase alfa 20mg powder for solut...
Virtual Medicinal Product Pack (VMPP) Information